Kura Oncology, Inc. Financial Ratios — KURA Stock

Profitability (USD)

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-51.05	-35.09	-42.78	-43.45	-29.76	-20.16	-22.09	-27.43	-33.72	-28.78	-37.19
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	100	99.92
EBITDA Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-356.97	-448.41
Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-358.55	-449.94
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-319.15	-412.51
Profit Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-322.89	-412.95
Net Income to Common Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-322.89	-412.95
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	3	- -	7	7	8	8	15	7	14	17	17	20
ST Debt	2	- -	- -	2	- -	1	5	2	2	2	4	1
LT Debt	- -	- -	7	6	8	7	10	5	12	16	12	19
Total Debt/EBITDA	- -	- -	-0.26	-0.2	-0.12	-0.11	-0.16	-0.05	-0.1	-0.1	-0.09	-0.07
Net Debt/EBITDA	- -	0.65	0.08	0.12	0.14	0.28	3.47	0.69	0.31	0.17	1.12	0.46
Total Debt/EBIT	- -	- -	-0.26	-0.2	-0.12	-0.11	-0.16	-0.05	-0.1	-0.1	-0.09	-0.07
Net Debt/EBIT	- -	0.65	0.08	0.12	0.14	0.28	3.46	0.69	0.3	0.17	1.11	0.46
EBITDA to Interest Expense	- -	-270.97	-49.11	-40.59	-64.82	-116.34	-158.66	-315.7	-607.45	-106.49	-118.81	-200.13
EBITDA-CapEx/Interest Expense	- -	-271.69	-49.11	-40.59	-64.82	-116.34	-162.42	-318.47	-610.18	-106.6	-119.1	-204.52
EBIT to Interest Expense	- -	-271.19	-49.16	-40.63	-64.83	-116.34	-158.99	-317.05	-610.76	-107.04	-119.33	-200.81
Interest Expense	- -	- -	1	1	1	1	1	- -	- -	2	2	2
Common Equity/Total Assets	-266.4	-30.13	-77.13	-93.15	-82.1	-87.97	-46.74	-81.07	-124.65	-160.7	-117.79	-159.01
Long-Term Debt/Equity (%)	- -	- -	12.88	6.97	4.66	3.31	1.62	0.91	2.79	3.95	2.93	11.01
Long-Term Debt/Capital (%)	-43.17	- -	-15.74	-6.77	-5.27	-3.53	-3.44	-1.08	-2.11	-2.23	-1.38	-1.66
Long-Term Debt/Total Assets (%)	35.78	- -	10.49	5.81	4.11	3	1.53	0.86	2.57	3.5	1.59	2.6
Total Debt/Equity (%)	-73.67	- -	12.88	8.89	4.66	3.54	2.45	1.36	3.34	4.33	4.01	11.75
Total Debt/Capital (%)	-221.45	- -	-15.74	-8.64	-5.27	-3.78	-5.21	-1.61	-2.53	-2.44	-1.89	-1.77
Total Debt/Total Assets (%)	183.53	- -	10.49	7.41	4.11	3.2	2.31	1.29	3.07	3.83	2.18	2.77
Net Debt to Equity	-40.93	-18.81	-4.22	-5.43	-5.35	-8.52	-52.09	-17.9	-10.15	-7.04	-51.96	-80.05
Net Debt/Capital (%)	-62	37	4.27	4.63	5.44	8.06	51.91	17.55	7.03	3.77	19.48	10.7
EBITDA	- -	-24	-28	-36	-63	-67	-92	-131	-139	-165	-192	-303
EBITDA-CapEx	- -	-24	-28	-36	-63	-67	-94	-132	-140	-165	-193	-309
Operating Income (Loss)	- -	-24	-28	-36	-63	-67	-92	-131	-140	-166	-193	-304

Liquidity (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.37	16.96	12.44	9.29	13.15	15.22	24.34	23.07	18.21	12.02	9.24	5.7
Current Ratio	0.4	17.18	12.62	9.43	13.31	15.39	24.49	23.26	18.56	12.26	9.46	6.06
Quick Ratio	0.38	17.05	12.49	9.31	13.16	15.22	24.34	23.07	18.21	12.02	9.27	5.78
CFO/Avg Current Liab	- -	-4.44	-4.83	-3.67	-4.12	-3.75	-3.36	-4.31	-4.73	-4.21	2.36	-0.65
Common Equity/Total Assets	-266.4	-30.13	-77.13	-93.15	-82.1	-87.97	-46.74	-81.07	-124.65	-160.7	-117.79	-159.01
Long-Term Debt/Equity (%)	- -	- -	12.88	6.97	4.66	3.31	1.62	0.91	2.79	3.95	2.93	11.01
Long-Term Debt/Capital (%)	-43.17	- -	-15.74	-6.77	-5.27	-3.53	-3.44	-1.08	-2.11	-2.23	-1.38	-1.66
Long-Term Debt/Total Assets (%)	35.78	- -	10.49	5.81	4.11	3	1.53	0.86	2.57	3.5	1.59	2.6
Total Debt/Equity (%)	-73.67	- -	12.88	8.89	4.66	3.54	2.45	1.36	3.34	4.33	4.01	11.75
Total Debt/Capital (%)	-221.45	- -	-15.74	-8.64	-5.27	-3.78	-5.21	-1.61	-2.53	-2.44	-1.89	-1.77
Total Debt/Total Assets (%)	183.53	- -	10.49	7.41	4.11	3.2	2.31	1.29	3.07	3.83	2.18	2.77
CFO/Total Liabilities	- -	-347.65	-195.82	-177.91	-227.42	-236.13	-192.33	-380.99	-305.49	-241.62	38.76	-11.35
CFO/CapEx	- -	-280.08	- -	- -	- -	- -	-32.16	-91.15	-175.82	-743	284.57	-9.65
Altman's Z-Score	-5.31	9.51	3.78	11.86	12.67	13.88	28.66	19.49	12.2	9.82	-0.07	-1.56

Working Capital (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	52.31	12.42
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.98	29.38
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.28
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,322.32
Accounts Payable Turnover	- -	3.52	2.36	0.91	0.38	- -	- -	- -	- -	- -	- -	0.14
Accounts Payable Turnover Days	- -	103.65	154.76	399.5	965.05	- -	- -	- -	- -	- -	- -	2,518.5
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,166.79
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1,292.94
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	83	110	356	494	577	1,733	929	831	1,053	750	911
- Cash & Cash Equivalents	1	15	10	11	16	26	325	91	52	37	224	149
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	- -	7	7	8	8	15	7	14	17	17	20
Enterprise Value	1	-2	50	269	323	348	1,115	418	407	646	40	264
Total Capital	-1	-26	-47	-82	-142	-205	-288	-426	-555	-704	-879	-1,154
Total Debt/Capital (%)	-221.45	- -	-15.74	-8.64	-5.27	-3.78	-5.21	-1.61	-2.53	-2.44	-1.89	-1.77
Total Debt / EV	1.8	- -	0.15	0.03	0.02	0.02	0.01	0.02	0.03	0.03	0.42	0.08
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.74	3.91
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.29	- -
Diluted Market Cap	- -	83	110	356	494	577	1,733	929	831	1,053	750	911
Diluted Enterprise Value	1	68	108	351	485	558	1,423	845	794	1,033	543	782
EV per Share	- -	- -	2.67	11.6	9.17	8.29	21.01	6.3	6.08	8.83	0.46	3.01
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	54	67
TTM EBITDA	- -	-24	-28	-36	-63	-67	-92	-131	-139	-165	-192	-303
TTM Operating Income	- -	-24	-28	-36	-63	-67	-92	-131	-140	-166	-193	-304
TTM Cash Flow to Firm	- -	-18	-25	-28	-48	-54	-69	-104	-110	-123	136	-63
TTM Free Cash Flow to Firm	- -	-18	-25	-28	-48	-54	-67	-103	-109	-123	136	-56

Multiples (USD)

API ChatGPT

	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	-4.67	-4.35	-12.5	-10.15	-10.53	-25.62	-8.98	-7.6	-8.45	5.57	-15.86
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	1	-2	50	269	323	348	1,115	418	407	646	40	264
Low Price	- -	6.72	2.5	5.6	10.2	12.65	6.35	12.02	10.41	7.41	8.42	5.41
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.74	3.91
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	-4.83	-3.1	-6.66	-10.01	-10.74	-12.36	-11.58	-7.25	-5.31	-9.23	-2.49
Price/Earnings High	- -	-10.98	-6.04	-11.48	-13.99	-14.23	-25.47	-20.35	-9.83	-7.22	-11.97	-3.93
Price/Earnings Low	- -	-2.95	-1.7	-3.67	-5.94	-8.4	-3.76	-6.11	-5.13	-3.56	-4.17	-1.7
Price/Book Value	- -	-3.17	-2.05	-3.98	-3.3	-2.71	-5.73	-2.15	-1.46	-1.46	-0.84	-0.78
Price/Book Value Average	- -	-4.16	-1.59	-2.64	-4.04	-3.18	-3.66	-3.49	-1.73	-1.12	-1.79	-0.59
Price/Book Value High	- -	-9.44	-3.09	-4.55	-5.65	-4.22	-7.54	-6.13	-2.35	-1.53	-2.33	-0.93
Price/Book Value Low	- -	-2.54	-0.87	-1.46	-2.4	-2.49	-1.11	-1.84	-1.23	-0.75	-0.81	-0.4
Price/Tangible Book Value	- -	1.02	1.94	4.45	3.07	2.64	2.84	1.83	1.98	2.65	1.81	5.23
Price/Tangible Book Value Average	- -	1.33	1.5	2.95	3.76	3.1	1.81	2.98	2.34	2.04	3.88	3.98
Price/Tangible Book Value High	- -	3.02	2.93	5.09	5.25	4.11	3.74	5.24	3.18	2.78	5.03	6.29
Price/Tangible Book Value Low	- -	0.81	0.82	1.63	2.23	2.43	0.55	1.57	1.66	1.37	1.75	2.72
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.93	13.5
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29.81	10.26
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	38.65	16.23
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.46	7.03
Price/Cash Flow	- -	-4.65	-4.35	-12.5	-10.15	-10.53	-24.82	-8.88	-7.55	-8.44	5.59	-14.22
Price/Cash Flow Average	- -	-6.1	-3.37	-8.29	-12.43	-12.38	-15.86	-14.45	-8.95	-6.49	11.96	-10.81
Price/Cash Flow High	- -	-13.85	-6.57	-14.3	-17.38	-16.41	-32.68	-25.39	-12.13	-8.83	15.5	-17.1
Price/Cash Flow Low	- -	-3.72	-1.84	-4.58	-7.38	-9.69	-4.83	-7.63	-6.34	-4.35	5.4	-7.4
Price/Free Cash Flow Average	- -	-6.12	-3.37	-8.29	-12.43	-12.38	-16.37	-14.61	-9	-6.5	11.92	-12.06
Price/Free Cash Flow High	- -	-13.9	-6.57	-14.3	-17.38	-16.41	-33.73	-25.67	-12.2	-8.84	15.45	-19.07
Price/Free Cash Flow Low	- -	-3.74	-1.84	-4.58	-7.38	-9.69	-4.98	-7.71	-6.37	-4.35	5.38	-8.26
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.96	8.36
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	34.79	14.32
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.61	5.12
EV/EBITDA Average	- -	-3.94	-2.93	-6.42	-9.48	-9.77	-8.69	-10.92	-6.81	-4.79	-7.27	-1.86
EV/EBITDA High	- -	-9.77	-5.79	-11.16	-13.31	-13.04	-21.5	-19.67	-9.33	-6.56	-9.75	-3.19
EV/EBITDA Low	- -	-2.15	-1.57	-3.49	-5.57	-7.59	-0.29	-5.46	-4.74	-3.17	-2.69	-1.14
EV/EBIT Average	- -	-3.93	-2.92	-6.42	-9.48	-9.77	-8.68	-10.87	-6.77	-4.77	-7.24	-1.86
EV/EBIT High	- -	-9.76	-5.78	-11.15	-13.31	-13.04	-21.46	-19.59	-9.28	-6.53	-9.7	-3.18
EV/EBIT Low	- -	-2.15	-1.56	-3.49	-5.57	-7.59	-0.29	-5.44	-4.72	-3.15	-2.68	-1.14
Last Price	- -	8.4	5.9	15.3	14.04	13.75	32.66	14	12.41	14.38	8.71	10.39
High Price	- -	25	8.9	17.5	24.02	21.42	43	40.01	19.93	15.06	24.17	12.49
Enterprise Value Average	1	94	83	232	596	660	797	1,427	947	790	1,399	564
Enterprise Value High	1	233	164	402	837	880	1,972	2,571	1,297	1,082	1,875	966
Enterprise Value Low	1	51	44	126	350	512	27	714	660	523	518	346

Shares Outstanding	21	21	21	30	38	45	66	67	68	74	78	88
Diluted Weighted Avg Shares	- -	10	19	23	35	42	53	66	67	73	86	88
Basic Weighted Avg Shares	- -	10	19	23	35	42	53	66	67	73	86	88
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.63	0.77
EBITDA per Share	- -	-2.4	-1.52	-1.55	-1.79	-1.61	-1.73	-1.97	-2.08	-2.25	-2.23	-3.45
Operating Income per Share	- -	-2.4	-1.52	-1.55	-1.79	-1.61	-1.73	-1.98	-2.09	-2.26	-2.24	-3.46
Basic EPS, GAAP	- -	-2.28	-1.47	-1.52	-1.72	-1.51	-1.69	-1.97	-2.03	-2.08	-2.02	-3.18
Basic EPS from Cont Ops	- -	-2.28	-1.47	-1.52	-1.72	-1.51	-1.69	-1.97	-2.03	-2.08	-2.02	-3.18
Diluted EPS, GAAP	- -	-2.28	-1.47	-1.52	-1.72	-1.51	-1.69	-1.97	-2.03	-2.08	-2.02	-3.18
Diluted EPS from Cont Ops	- -	-2.28	-1.47	-1.52	-1.72	-1.51	-1.69	-1.97	-2.03	-2.08	-2.02	-3.18
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	-1.8	-1.36	-1.22	-1.38	-1.31	-1.32	-1.58	-1.64	-1.7	1.56	-0.73
Free Cash Flow per Basic Share	- -	-1.81	-1.36	-1.22	-1.38	-1.31	-1.36	-1.59	-1.65	-1.71	1.55	-0.81
Cash & Equivalents per Share	- -	8.63	3.62	4.01	5.09	5.65	11.93	7.81	6.54	5.79	8.44	7.61
Book Value per Share	- -	-2.65	-2.88	-3.84	-4.25	-5.07	-5.7	-6.53	-8.49	-9.85	-10.39	-13.39
Tangible Book Value per Share	- -	8.27	3.04	3.44	4.57	5.22	11.51	7.64	6.27	5.43	4.8	1.99

Kura Oncology, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)